ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX
· Real-Time Price · USD
1.93
0.01 (0.52%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.00%
After-hours: Aug 15, 2025, 07:33 PM EDT
ESSA Pharma Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 46.7K | 38.17K | 67.88K | 95.03K | 102.81K | 117.75K | 118.49K | 121.79K | 121.79K | 121.79K | 121.79K | 120.14K | 115.19K | 112.33K | 81.88K | 53.08K | 27.58K | n/a |
Gross Profit | -46.7K | -38.17K | -67.88K | -95.03K | -102.81K | -117.75K | -118.49K | -121.79K | -121.79K | -121.79K | -121.79K | -120.14K | -115.19K | -112.33K | -81.88K | -53.08K | -27.58K | n/a |
Operating Income | -27.75M | -30.87M | -26.32M | -29.99M | -27.62M | -24.21M | -25.59M | -26.53M | -29.02M | -32.86M | -35.2M | -38M | -38.58M | -39.54M | -37.14M | -32.35M | -27.88M | -25.48M |
Interest Income | 1.01M | n/a | 1.64M | 3.31M | 4.92M | 6.08M | 5.55M | 4.64M | 3.45M | 2.77M | 1.74M | 1.05M | 716.43K | 273.89K | 235K | 236.06K | 328.01K | 494.44K |
Pretax Income | -28.5M | -31.11M | -28.54M | -27.67M | -27.73M | -25.8M | -26.58M | -27.49M | -29.06M | -32.86M | -35.21M | -37.38M | -37.26M | -39.37M | -36.84M | -32.83M | -29.01M | -25.4M |
Net Income | -28.5M | -31.11M | -28.54M | -27.67M | -27.73M | -25.81M | -26.57M | -27.41M | -28.94M | -32.67M | -35.03M | -37.27M | -37.2M | -39.37M | -36.81M | -32.78M | -28.96M | -25.35M |
Selling & General & Admin | 15.24M | 15.67M | 13.65M | 11.98M | 11.62M | 11.05M | 11.21M | 11.9M | 11.84M | 11.83M | 12.28M | 12.43M | 12.76M | 13.63M | 12.8M | 12.08M | 11.13M | 11.37M |
Research & Development | 18.61M | 21.3M | 21.21M | 22.25M | 23.05M | 21.36M | 21.32M | 20.45M | 20.57M | 23.74M | 24.41M | 26.34M | 26.17M | 25.79M | 24.26M | 20.22M | 16.69M | 14.05M |
Other Expenses | -917.42K | -917.42K | -917.42K | 63.78K | 63.78K | 63.78K | n/a | -63.78K | 71.94K | 167.44K | 261.67K | 290.47K | 180.25K | 112.33K | 124.88K | 132.08K | 106.58K | 79K |
Operating Expenses | 32.68M | 35.8M | 33.73M | 33.86M | 34.13M | 31.87M | 32.13M | 32.11M | 32.49M | 35.74M | 36.96M | 39.05M | 39.11M | 39.53M | 37.14M | 32.35M | 27.88M | 25.48M |
Interest Expense | n/a | n/a | n/a | 1.12K | 2.65K | 4.59K | 6.94K | 8.82K | 10.44K | 12.02K | 14K | 15.07K | 28.59K | 25.36K | 22.04K | 134.97K | 315.4K | 403.47K |
Selling & Marketing Expenses | 33.59K | -202.53K | -202.53K | -202.53K | -236.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.96M | 36.07M | 33.75M | 33.88M | 34.15M | 31.87M | 32.13M | 32.11M | 32.49M | 35.74M | 36.96M | 39.05M | 39.11M | 39.53M | 37.14M | 32.35M | 27.88M | 25.48M |
Income Tax Expense | 20.27K | 20.27K | n/a | -19.15K | -17.63K | -15.62K | -6.88K | -74.01K | -121.3K | -192.24K | -180.61K | -110.53K | -63.97K | 5.27K | -29.83K | -48.9K | 147.4K | 151.1K |
Shares Outstanding (Basic) | 44.39M | 44.37M | 44.37M | 44.37M | 44.24M | 44.13M | 44.1M | 44.09M | 44.09M | 44.07M | 44.07M | 44.06M | 44.03M | 43.99M | 41.02M | 41.02M | 36.48M | 33.34M |
Shares Outstanding (Diluted) | 44.39M | 44.37M | 44.37M | 44.37M | 44.24M | 44.13M | 44.1M | 44.09M | 44.09M | 44.07M | 44.07M | 44.06M | 44.03M | 43.99M | 41.02M | 41.02M | 36.48M | 33.34M |
EPS (Basic) | -0.63 | -0.69 | -0.64 | -0.62 | -0.63 | -0.59 | -0.6 | -0.62 | -0.65 | -0.73 | -0.79 | -0.86 | -0.87 | -0.99 | -0.98 | -0.94 | -0.97 | -1.06 |
EPS (Diluted) | -0.63 | -0.69 | -0.64 | -0.62 | -0.63 | -0.59 | -0.6 | -0.62 | -0.65 | -0.73 | -0.79 | -0.86 | -0.87 | -0.99 | -0.98 | -0.94 | -0.97 | -1.06 |
EBITDA | -28.4M | -31.03M | -28.45M | -27.57M | -27.63M | -25.68M | -26.46M | -27.36M | -28.93M | -32.73M | -35.08M | -37.25M | -37.12M | -39.24M | -36.71M | -32.59M | -28.58M | -24.87M |
EBIT | -29.88M | -32.5M | -28.54M | -27.67M | -27.73M | -25.8M | -26.57M | -27.48M | -29.05M | -32.85M | -35.2M | -37.37M | -37.23M | -39.35M | -36.82M | -32.69M | -28.7M | -24.99M |
Depreciation & Amortization | 1.39M | 1.38M | n/a | 95.03K | 102.81K | 117.75K | 118.49K | 121.79K | 121.79K | 121.79K | 121.79K | 120.14K | 115.19K | 112.33K | 109.46K | 94.52K | 101.17K | 110.32K |